Kairos Pharma, Ltd.'s total assets for Q3 2025 were $8.07M, an increase of 20.88% from the previous quarter. KAPA total liabilities were $402.00K for the fiscal quarter, a -40.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.